Network analyses elucidate the role of SMYD3 in esophageal squamous cell carcinoma

Xinning Liu1,2, Zhoude Zheng1,2, Chuhong Chen1,2

  • 1Key Laboratory of Molecular Biology in High Cancer Incidence Coastal Chaoshan Area of Guangdong Higher Education Institutes Shantou University Medical College China.

FEBS Open Bio
|August 8, 2017
PubMed

Insights

SMYD3, a protein linked to cancer, was studied in esophageal squamous cell carcinoma (ESCC) cells. Analyzing gene expression and protein interactions revealed new roles for SMYD3 in regulating gene expression and cellular processes.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Bioinformatics

Background:

  • SMYD3 (SET and MYND domain-containing protein 3) is a methyltransferase implicated in carcinogenesis.
  • Elevated SMYD3 expression correlates with poorer survival in esophageal squamous cell carcinoma (ESCC).

Purpose of the Study:

  • To investigate novel biological roles and target genes of SMYD3 in ESCC.
  • To analyze gene expression data integrated with protein-protein interaction (PPI) networks.

Main Methods:

  • Gene expression data from SMYD3-knockdown ESCC cells (KYSE150) were analyzed.
  • Protein-protein interaction (PPI) network construction and enrichment analyses (DAVID, Gene Ontology) were performed.
  • Subcellular localization of differentially expressed genes (DEGs) and interacting proteins was assessed.

Main Results:

  • SMYD3 knockdown led to thousands of differentially expressed genes (DEGs) interacting within a PPI network.
  • Enrichment analyses identified significant Gene Ontology (GO) terms related to transcription, including potential targets like YAP1 and GATA3.
  • The analysis revealed 532 significant GO 'Biological Process' terms, highlighting SMYD3's roles in gene regulation, signal transduction, cell cycle, metastasis, and invasion.
  • DEGs and interacting proteins showed complex subcellular distributions.

Conclusions:

  • The study provides a comprehensive functional map of SMYD3's biological roles in ESCC.
  • The identified PPI network and DEGs offer valuable insights into SMYD3's mechanisms and potential therapeutic targets.
  • Further research can elucidate the precise roles of SMYD3 and its target genes in cancer progression.